{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:53:51Z","timestamp":1785855231575,"version":"3.56.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1097\/01.ftd.0000161930.34775.45","type":"journal-article","created":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T04:02:57Z","timestamp":1116475377000},"page":"263-264","source":"Crossref","is-referenced-by-count":10,"title":["Cyclophosphamide Hypersensitivity in a Leukemic Child"],"prefix":"10.1097","volume":"27","author":[{"given":"Miguel A","family":"Rosas-Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begonia","family":"Casas-Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadira","family":"Vel\u00e1zquez-Armenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J. L","family":"Sienra-Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca E. Del","family":"R\u00edo-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199819010-00001","article-title":"The role of the WHO program on International Drug Monitoring in coordinating worldwide drug safety efforts.","volume":"19","author":"Olsson","year":"1998","journal-title":"Drug Saf"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"issue":"Suppl 5","key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-9995.1999.tb04740.x","article-title":"Drug allergy: relationship between immunogenicity and clinical symptoms.","volume":"4","author":"Pichler","year":"1999","journal-title":"Allergy"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0091-6749(96)70279-8","article-title":"Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients.","volume":"97","author":"Popescu","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"R6-1-20210129","first-page":"57","article-title":"Anaphylactoid reaction to cyclophosphamide in a patient with T cell lymphoma and hemophagocytic syndrome.","volume":"69","author":"Minami","year":"1999","journal-title":"Int J Hematol"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF01714904","article-title":"Anaphylactoid reaction with bronchospasm following intravenous cyclophosphamide administration.","volume":"62","author":"Salles","year":"1991","journal-title":"Ann Hematol"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jama.1977.03270320053025","article-title":"Possible anaphylactic reaction to intravenous cyclophosphamide. Report of a case.","volume":"237","author":"Karchmer","year":"1977","journal-title":"JAMA"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0091-6749(76)90151-2","article-title":"Generalized urticaria to cyclophosphamide: Type I hypersensitivity to an immunosuppressive agent.","volume":"58","author":"Lakin","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for the skin test procedures in the diagnosis of drug hypersensitivity.","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/jm00385a029","article-title":"The mechanism of activation of 4-hydroxycyclophosphamide.","volume":"30","author":"Borch","year":"1987","journal-title":"J Med Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ftd.0000161930.34775.45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:31:25Z","timestamp":1785853885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200506000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000161930.34775.45","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}